Oral Drug Delivery Resources
-
Microphysiological Systems: Closing The Gap Between Models And Medicine
9/2/2025
Microphysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.
-
Harness High-Quality PBPK Modeling To Enhance Clinical Readiness
Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties.
-
A Technical Package That Serves On-Time Injectable Project Completion
4/24/2023
The accuracy, robustness, and completeness of the technical package an organization submits to its development and/or manufacturing partner is critical to meeting fill project timelines.
-
Capsule Formulation Development: From Dosage Forms To Filling
5/4/2022
Capsules are tasteless and easy to take, offer streamlined development timelines, and simplicity of manufacturing. Discover capsule formulation development and the benefits of capsule dosage forms.
-
Maintaining Drug Bioavailability And Masking Taste With Microencapsulation
8/24/2022
Several technologies are available for microencapsulating drugs. Finding the right CDMO to optimize a drug’s efficacy and manufacturing during formulation is integral to its clinical and commercial success.
-
Customized Release Through Dispersed Dosage Formats
6/13/2024
Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges
2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Zydis® Orally Disintegrating Tablet (ODT) Vs. Standard Tablets (ST)
7/28/2023
Review how Zydis ODT compares against standard oral tablets, how the same molecule can produce a different outcome when utilizing Zydis ODT, and findings from over 20 published studies.
-
Integrated First-In-Human Services To Streamline End-To-End Development And Manufacturing
6/1/2022
Lonza’s SimpliFiH®️ Solutions offering is designed to simplify and accelerate the development pathway, even for APIs with challenging properties, such as low aqueous solubility and poor bioavailability.
-
Less Mess, Less Stress, Best Expressed: An Alternative To Spray Drying
7/16/2024
Although well-established processes, spray drying and hot-melt extrusion can be outperformed in bioavailability, cost-savings, manufacturing speed, environmental impact, and more.